Sumitomo Pharma : Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including Representative Directors, Executive Officer, and the Positions Assumed by Executive Officers

May 14, 2024

Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including Representative Directors, Executive Officer, and the Positions Assumed by Executive Officers

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director,

President and CEO: Hiroshi Nomura; Securities Code: 4506, Prime Market of TSE) announced today that in its meeting held on May 14, 2024, the Board of Directors appointed the following candidates for new assignments of Representative Directors including President and CEO, new members of the Board of Directors, and a new Executive Officer. The Company will also change the positions assumed by Executive officers.

1. Changes in Representative Directors (including President and CEO) and

Executive Officer

1. New Assignments of Representative Directors (including President and CEO) and Executive Officer

Name	New position	Current position
Toru	Representative Director,	Representative Director,
Kimura	President and CEO	Senior Managing Executive Officer
Motoyuki	Representative Director,	Representative Director & Senior
Managing Executive Officer
Sakai	Executive Vice President
Sumitomo Chemical Co., Ltd.
Hiroshi	Corporate Senior	Representative Director,
Nomura	Executive Advisor	President and CEO

(2) Reason for Changes

The Company has been facing challenging performance with significant losses in both the fiscal year ended March 31, 2023 and the fiscal year ended March 31, 2024, which are net profit attributable to owners of the parent. To achieve an early recovery in performance and regrowth, the Company is implementing various measures and receiving personnel support from Sumitomo Chemical Co., Ltd. Consequently, the Company has decided to transition to a new management structure led by a new President and CEO and a new Executive Vice President, with the full cooperation of the entire company, aiming to turn its performance into profitability.

(3) Effective Date

June 25, 2024 (The new members who will take office as of June 25, 2024 are subject to the approval at the general shareholders' meeting scheduled for the same date and then to be formally decided at the Board of Directors scheduled for the same date.)

1

1. Changes in the Members of the Board of Directors (effective June 25, 2024)

(1) New Members of the Board of Directors

Name	New position	Current position
Tsutomu	Member,
Board of Directors,	Executive Officer
Nakagawa
Executive Officer
Hiroshi	Member,	Director & Executive Vice
President
Niinuma	Board of Directors
Sumitomo Chemical Co., Ltd.

The new members of the Board of Directors who will take office as of June 25, 2024 are subject to the approval at the general shareholders' meeting scheduled for the same date.

Hiroshi Niinuma is a candidate for non-executive Director and continues to serve as a Director & Executive Vice President of Sumitomo Chemical Co., Ltd. (concurrent position).

(2) Departing Members of the Board of Directors

Name	New position	Current position
Yoshiharu	Managing Executive	Member, Board of Directors,
Ikeda	Officer	Managing Executive Officer
Hiroyuki	Managing Executive	Member, Board of Directors,
Baba	Officer	Managing Executive Officer
Shigeyuki	Managing Executive	Member, Board of Directors,
Nishinaka	Officer	Managing Executive Officer

1. Changes in the Positions Assumed by Executive Officers (effective June 25, 2024)

Position as of June 25, 2024	Current position	Name
Representative Director,
Executive Vice President	Representative Director &
Global Corporate Strategy	Senior Managing Executive	Motoyuki
Corporate Governance	Officer	Sakai
Human Resources	Sumitomo Chemical Co., Ltd.
Global Finance Administration
Executive Officer
Global Corporate Strategy	Executive Officer	Yutaka
Global Finance	Vice President, Head of Global
Wakemi
Vice President, Head of Global	Corporate Strategy
Corporate Strategy

2

(Reference)

Brief Personal History of New President and CEO

Name: Toru Kimura

Birthdate: August 5, 1960 (63 years old)

Birthplace: Shiga Prefecture, Japan

Education: March 1989 Ph.D., Department of Biophysics,

Graduate School of Science, Kyoto University

Business Career

April 1989 Joined Sumitomo Chemical Co., Ltd.

October	Joined the former Sumitomo Pharmaceuticals Co., Ltd.
1992
June 2009	Vice President, Head of Genomic Science Laboratories of the
	Company
June 2010	Vice President, Head of Research Planning & Management of
	the Company
April 2012	Vice President, Head of Global Strategy of the Company
September	Vice President, Head of the Regenerative & Cellular Medicine
2013	Office of the Company
April 2015	Executive Officer of the Company
	Vice President, Head of the Regenerative & Cellular Medicine
	Office
June 2016	Member of the Board of Directors and Executive Officer of the
	Company
	Vice President, Head of Global Corporate Strategy
	Regenerative & Cellular Medicine Office
October	Member of the Board of Directors and Executive Officer of the
2017	Company
	Senior Executive Research Director of Drug Research
	Division
	Regenerative & Cellular Medicine Office; Regenerative &
	Cellular Medicine Kobe Center
April 2019	Member of the Board of Directors and Managing Executive
	Officer of the Company
	Senior Executive Research Director of Drug Research
	Division
	Regenerative & Cellular Medicine Office; Regenerative &
	Cellular Medicine Kobe Center; Regenerative & Cellular
	Medicine Manufacturing Plant
April 2020	Member of the Board of Directors and Managing Executive
	Officer of the Company
	Chief Scientific Officer
	Senior Executive Research Director of Drug Research
	3

Division

Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant

April 2021 Representative Director and Senior Managing Executive Officer of the Company

Chief Scientific Officer

Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant

April 2022 Representative Director and Senior Managing Executive Officer of the Company

Global Corporate Strategy; Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant

April 2023 Representative Director and Senior Managing Executive Officer of the Company

Global Corporate Strategy; Global Finance; Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant (to the present)

(Reference)

Brief Personal History of candidates for new members of the Board of Directors

(1) Motoyuki SakaiBirthdate: August 14, 1961

April 1985 Joined Sumitomo Chemical Co., Ltd.

June 2007 General Manager, Finance & Accounting Office (Accounting), Sumitomo Chemical Co., Ltd.

July 2010 General Manager, Corporate Planning & Coordination Office (Corporate Planning), Sumitomo Chemical Co., Ltd.

April 2013 General Manager, Corporate Planning & Coordination Office (Business Development), Sumitomo Chemical Co., Ltd.

April 2014 Executive Officer, Sumitomo Chemical Co., Ltd.

April 2018 Managing Executive Officer, Sumitomo Chemical Co., Ltd. President and Representative Director, Sumitomo Chemical Asia Pte Ltd

April 2023 Senior Managing Executive Officer, Sumitomo Chemical Co., Ltd.

June 2023 Representative Director & Senior Managing Executive Officer,

Sumitomo Chemical Co., Ltd. (to the present)

Company shares owned: 0
(2) Tsutomu Nakagawa	Birthdate:	April 27, 1968
April 1993	Joined the former Sumitomo Pharmaceuticals Co., Ltd.
April 2016	Senior Officer of Global Oncology of the Company
April 2017	Senior Officer of Global Oncology（Development Strategy） of the
		4

Company

April 2019 Vice President, Head of Global Oncology Office of the Company

April 2020 Vice President, Head of Global Corporate Strategy of the Company

April 2022 Executive Officer of the Company

July 2023 Chief Strategy Officer of Sumitomo Pharma America, Inc.

April 2024 President and CEO of Sumitomo Pharma America, Inc. (to the present)

(3) Hiroshi Niinuma	Birthdate:	March 5, 1958
April 1981	Joined Sumitomo Chemical Co., Ltd.
April 2006	General Manager, Personnel Office, Sumitomo Chemical Co., Ltd.
April 2007	General Manager, Human Resources Dept., Sumitomo Chemical
	Co., Ltd.
April 2009	General Manager, General Affairs Dept., Sumitomo Chemical Co.,
	Ltd.
April 2010	Executive Officer, Sumitomo Chemical Co., Ltd.
April 2013	Managing Executive Officer, Sumitomo Chemical Co., Ltd.
April 2018	Senior Managing Executive Officer, Sumitomo Chemical Co., Ltd.
June 2018	Director & Senior Managing Executive Officer, Sumitomo
	Chemical Co., Ltd.
April 2022	Director & Executive Vice President, Sumitomo Chemical Co.,
	Ltd.	(to the present)

(Reference)

Members of the Board of Directors and the Audit & Supervisory Board after approval at the general shareholders' meeting (from June 25, 2024)

Board of Directors
Toru Kimura	Representative Director, President and CEO
Motoyuki Sakai	Representative Director, Executive Vice President
Tsutomu Nakagawa	Member, Board of Directors, Executive Officer
Hiroshi Niinuma	Member, Board of Directors,
Saeko Arai	Member, Board of Directors (Outside)
Nobuhiro Endo	Member, Board of Directors (Outside)
Minoru Usui	Member, Board of Directors (Outside)
Koji Fujimoto	Member, Board of Directors (Outside)
Audit & Supervisory Board
Takashi Kutsunai	Audit & Supervisory Board Member
Hisayoshi Kashima	Audit & Supervisory Board Member
Yoshio Iteya	Audit & Supervisory Board Member (Outside)
Mayumi Mochizuki	Audit & Supervisory Board Member (Outside)
Daishiro Michimori	Audit & Supervisory Board Member (Outside)

5

Contact:

Corporate Communications

Sumitomo Pharma Co., Ltd.

E-mail：[e-mail]

6